Leonis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.50 M
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 2.66 Cr
About Leonis Pharmaceuticals
Leonis Pharmaceuticals Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 September 2003 and has a history of 21 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.50 M.
The company currently has active open charges totaling ₹2.66 Cr.
Binay Singh, Debasish Sircar, and Nilesh Parekh serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2003PTC142341
- Company No.
142341
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2003
- Date of AGM
25 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Leonis Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binay Singh  | Director | 23-Sep-2003 | Current |
| Debasish Sircar | Director | 16-Nov-2009 | Current |
| Nilesh Parekh | Director | 09-Mar-2005 | Current |
Financial Performance of Leonis Pharmaceuticals.
Enhance accessibility to Leonis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Leonis Pharmaceuticals?
Unlock access to Leonis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shankram Construction And Builders Private LimitedBinay Singh is a mutual person
Charges (Loans)
₹2.66 Cr
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 2.66 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2006 | Syndicate Bank | ₹2.66 Cr | Open |
How Many Employees Work at Leonis Pharmaceuticals?
Unlock and access historical data on people associated with Leonis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leonis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leonis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
